Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1497 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.35 USD | -2.46% | +1.52% | +11.58% | +46.87% | 4.05 B USD | ||
| 1517 |  LEGN Legend Biotech Corporation - American Depositary Shares | 21.01 USD | -3.71% | +3.29% | +2.24% | -34.30% | 3.89 B USD | ||
| 1519 |  TNGX Tango Therapeutics, Inc. - Common Stock | 23.16 USD | -3.02% | -9.57% | -13.52% | +238.10% | 3.91 B USD | ||
| 1522 |  DNLI Denali Therapeutics Inc. - Common Stock | 23.75 USD | -4.70% | -2.22% | +0.68% | +46.88% | 3.80 B USD | ||
| 1531 |  VKTX Viking Therapeutics, Inc. - Common Stock | 32.94 USD | -2.80% | -0.18% | -6.98% | +27.62% | 3.84 B USD | ||
| 1549 |  RCUS Arcus Biosciences, Inc. Common Stock | 29.71 USD | -2.11% | +0.20% | +3.23% | +181.08% | 3.78 B USD | ||
| 1554 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.62 USD | +2.56% | -0.77% | +14.60% | +84.15% | 3.94 B USD | ||
| 1556 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 39.29 USD | -0.96% | +8.12% | +8.06% | +20.60% | 3.79 B USD | ||
| 1565 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 7.89 USD | -4.83% | +15.86% | +57.17% | +207.00% | 3.57 B USD | ||
| 1614 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 47.99 USD | -2.24% | -11.88% | -2.76% | +79.47% | 3.42 B USD | ||
| 1618 |  ABCL AbCellera Biologics Inc. - Common Shares | 10.76 USD | -4.95% | -2.00% | +100.00% | +147.36% | 3.30 B USD | ||
| 1635 |  VCYT Veracyte, Inc. - Common Stock | 41.25 USD | -2.51% | -1.01% | -28.61% | +11.79% | 3.32 B USD | ||
| 1650 |  QURE uniQure N.V. - Ordinary Shares | 46.80 USD | -3.25% | -1.74% | +21.56% | +199.23% | 3.25 B USD | ||
| 1655 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 26.90 USD | -3.48% | +0.79% | -10.66% | -25.83% | 3.22 B USD | ||
| 1673 |  IMNM Immunome, Inc. - Common Stock | 27.89 USD | -2.21% | +3.33% | +23.46% | +168.69% | 3.17 B USD | ||
| 1688 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.77 USD | -1.28% | +3.56% | +22.18% | +8.64% | 3.15 B USD | ||
| 1695 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.93 USD | -1.11% | -5.18% | +11.91% | +46.59% | 3.14 B USD | ||
| 1701 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.78 USD | -1.20% | -4.98% | -10.28% | +54.88% | 3.11 B USD | ||
| 1706 |  ALMS Alumis Inc. - Common Stock | 22.95 USD | -5.05% | -8.35% | -17.42% | +408.87% | 2.97 B USD | ||
| 1707 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 14.28 USD | -7.63% | +14.15% | +26.82% | +647.64% | 2.88 B USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |